PROM1 and familial pancreatic carcinoma: CD133 has been used to detect the CSCs of various malignant diseases, including leukemia, brain tumors, colon carcinoma, prostate cancer, liver carcinoma, lung cancer, pancreas carcinoma, and malignant melanoma.